Immunophenotyping identifies key immune biomarkers for coronary artery disease through machine learning.

Abstract

Authors

• Lelin Jiang
  Department of Clinical Medicine, The Second Clinical Medical College of Wenzhou Medical University, Wenzhou, Zhejiang, China.
• Minghao Jiang
  Department of Surgery, The Second Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
• Yiying Liu
  Wenzhou Central Hospital, Wenzhou, Zhejiang, China.
• Wei Zhao
  Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, Jiangnan University, Wuxi 214122, Jiangsu Province, P. R. China. lxy@jiangnan.edu.cn zhuye@jiangnan.edu.cn.
• Xinlang Zhou
  Department of Cardiology, Wenzhou Integrated Traditional Chinese and Western Medicine Hospital, Wenzhou, Zhejiang, China.
• Ying Liu
  The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
• Shue Huang
  Department of Cardiology, Wenzhou Integrated Traditional Chinese and Western Medicine Hospital, Wenzhou, Zhejiang, China.
• Lina Chen
  Department of Ophthalmology, The Third People's Hospital of Dalian, Dalian, Liaoning Province, China.
• Wenbing Jiang
  Department of Cardiology, Wenzhou Integrated Traditional Chinese and Western Medicine Hospital, Wenzhou, Zhejiang, China.

Keywords

External Resources